The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole for 4weeks for Erosive Esophagitis Without Any Appointments
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- The number of patients who revisit our outpatient clinic after the prescription without any appointments
研究概览
简要总结
After vonoprazan (20mg/day) or esomeprazole (20mg/day) for 4weeks is prescribed for patients with erosive esophagitis diagnosed by esophagogastroduodenoscopy, the number of patients who will visit our outpatient clinic again due to some reasons without any appointments is compared with vonoprazan group and esomeprazole.
详细描述
- Patients who have erosive esophagitis diagnosed by esophagogastroduodenoscopy is enrolled.
- Vonoprazan (20mg/day) or esomeprazole (20mg/day) is prescribed for 4weeks the patients randomly without next appointments.
- Some patients may visit our outpatient clinic again due to some reasons without any appointments.
- The number of the patients who revisit our outpatient clinic again is compared with vonoprazan group and esomeprazole.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •outpatients belonging to American Society of Anesthesiologists class I or II
- •patients have erosive esophagitis diagnosed by esophagogastroduodenoscopy shortly before the prescription
排除标准
- •other acid blockers are taken
研究组 & 干预措施
Vonoprazan
Vonoprazan (20mg/day) is prescribed for patients with erosive esophagitis
干预措施: Vonoprazan (Drug)
Esomeprazole
Esomeprazole (20mg/day) is prescribed for patients with erosive esophagitis
干预措施: Esomeprazole (Drug)
结局指标
主要结局
The number of patients who revisit our outpatient clinic after the prescription without any appointments
时间窗: 3 months
The need to revisit our outpatient clinic again without any appointments may show the patients' satisfaction or dissatisfaction after the prescription of vonoprazan or esomeprazole. The difference in the number between the two groups may show the difference in the effectiveness between the two medicines.
次要结局
- Change of the main symptom with patients after/before medication when the patients revisit again(3 months)
研究者
Akira Horiuchi
Chief of Digestive Disease Center
Showa Inan General Hospital